Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$52.835 1.145 | 2.22%
10/21/14 - 02:36 PM ET
Company Profile
Price and Volume
Recent Price 51.69
52 Week High 55.70
52 Week Low 36.26
Avg. Daily Vol. (Mil) 3.83
Beta (3 year) 0.77
Share Related Items
Mkt Cap (Mil) 44,143.26
Shares Out (Mil) 854.00
Float (Mil) 0.00
Dividend Information
Yield % 2.30
Annual Dividend 1.20
Payout Ratio 38.00
Financial Strength
Quick Ratio 0.50
Current Ratio 1.10
LT Debt/ Equity 0.39
Total Debt / Equity 0.47
Valuation Ratios
Price Earnings 17.00
Price/Sales 2.15
Price/Book 1.88
Price/Cash Flow 10.50
Per Share Data
Earnings 3.03
Sales 24.05
Book Value 27.56
Cash Flow 4.92
Business Summary
Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Some of its products are Copaxone, Azilect & Provigil.
General Information
5 Basel Street
P.O. Box 3190
Petach Tikva, 4951033
www.tevapharm.com
Industry : Drugs
Sector: Health Care
Employees: 45000
CEO: Mr. Erez Vigodman
Short Interest
Current Month (Mil) 5.07
Previous Month (Mil) 5.68
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity 10.90
Return on Assets 5.50
Return on Investments 7.90
Profitability
Gross Margin 60.90
EBIT Margin 16.60
Profit Margin 12.50

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter